Register entry
TerSera Therapeutics LLC
- Registered sites
- 0
- Drug products
- 9
- Live patents
- 20
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
20Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| QMIIZ ODT | MELOXICAM | Aug 2030 |
| VARUBI | ROLAPITANT HYDROCHLORIDE | Apr 2027 |
| VARUBI | ROLAPITANT HYDROCHLORIDE | Aug 2028 |
| VARUBI | ROLAPITANT HYDROCHLORIDE | Jan 2029 |
| VARUBI | ROLAPITANT HYDROCHLORIDE | Oct 2029 |
| VARUBI | ROLAPITANT HYDROCHLORIDE | Jul 2032 |
| XERMELO | TELOTRISTAT ETIPRATE | Dec 2027 |
| XERMELO | TELOTRISTAT ETIPRATE | Dec 2028 |
| XERMELO | TELOTRISTAT ETIPRATE | Feb 2031 |
| XERMELO | TELOTRISTAT ETIPRATE | Feb 2031 |
Catalogue
Marketed products
9Showing 9 of 9.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| MARGENZA | margetuximab-cmkb | INJECTION, SOLUTION, CONCENTRATE | BLA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| PRIALT | ziconotide acetate | INJECTION, SOLUTION | NDA |
| QUZYTTIR | Cetirizine Hydrochloride | INJECTION | NDA |
| Varubi | rolapitant | TABLET | NDA |
| Xermelo | telotristat ethyl | TABLET | NDA |
| ZOLADEX | goserelin | IMPLANT | NDA |
| ZOLADEX | goserelin | IMPLANT | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.